Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients.

Literature DB >> 19017052

Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients.

Mariko Kashiwagi, Michiko Aihara, Yukitoshi Takahashi, Etsuko Yamazaki, Yumiko Yamane, Yixuan Song, Masaaki Muramatsu, Zenro Ikezawa.

Abstract

Entities: Chemical Species

Mesh：

Substances：

Year: 2008 PMID： 19017052 DOI： 10.1111/j.1346-8138.2008.00548.x

Source DB: PubMed Journal: J Dermatol ISSN： 0385-2407 Impact factor: 4.005

Keyword Cloud
Cited

× No keyword cloud information.

13 in total

1. Carbamazepine hypersensitivity: progress toward predicting the unpredictable.

Authors: Barry E Gidal
Journal: Epilepsy Curr Date: 2011-11 Impact factor: 7.500

2. HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans.

Authors: Mark McCormack; Ana Alfirevic; Stephane Bourgeois; John J Farrell; Dalia Kasperavičiūtė; Mary Carrington; Graeme J Sills; Tony Marson; Xiaoming Jia; Paul I W de Bakker; Krishna Chinthapalli; Mariam Molokhia; Michael R Johnson; Gerard D O'Connor; Elijah Chaila; Saud Alhusaini; Kevin V Shianna; Rodney A Radtke; Erin L Heinzen; Nicole Walley; Massimo Pandolfo; Werner Pichler; B Kevin Park; Chantal Depondt; Sanjay M Sisodiya; David B Goldstein; Panos Deloukas; Norman Delanty; Gianpiero L Cavalleri; Munir Pirmohamed
Journal: N Engl J Med Date: 2011-03-24 Impact factor: 91.245

Review 3. Pharmacokinetics and Pharmacogenetics of Carbamazepine in Children.

Authors: Natasa Djordjevic; Slobodan M Jankovic; Jasmina R Milovanovic
Journal: Eur J Drug Metab Pharmacokinet Date: 2017-10 Impact factor: 2.441

Review 4. The risk of cutaneous adverse reactions among patients with the HLA-A* 31:01 allele who are given carbamazepine, oxcarbazepine or eslicarbazepine: a perspective review.

Authors: Nahoko Kaniwa; Yoshiro Saito
Journal: Ther Adv Drug Saf Date: 2013-12

5. Clinical features of and genetic predisposition to drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a single Korean tertiary institution patients-investigating the relation between the HLA -B*4403 allele and lamotrigine.

Authors: Hye Jung Park; Sung Ryeol Kim; Dong Woo Leem; Il Joo Moon; Beom Seok Koh; Kyung Hee Park; Jung-Won Park; Jae-Hyun Lee
Journal: Eur J Clin Pharmacol Date: 2014-10-21 Impact factor: 2.953

6. Human Leukocyte Antigen (HLA) Testing in Pharmacogenomics.

Authors: Ann M Moyer; Manish J Gandhi
Journal: Methods Mol Biol Date: 2022

Review 7. Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS)/Drug-Induced Hypersensitivity Syndrome (DiHS)-Readdressing the DReSS.

Authors: Hannah Stirton; Neil H Shear; Roni P Dodiuk-Gad
Journal: Biomedicines Date: 2022-04-26

Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients.

1. Carbamazepine hypersensitivity: progress toward predicting the unpredictable.

2. HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans.

Review 3. Pharmacokinetics and Pharmacogenetics of Carbamazepine in Children.

Review 4. The risk of cutaneous adverse reactions among patients with the HLA-A* 31:01 allele who are given carbamazepine, oxcarbazepine or eslicarbazepine: a perspective review.

5. Clinical features of and genetic predisposition to drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a single Korean tertiary institution patients-investigating the relation between the HLA -B*4403 allele and lamotrigine.

6. Human Leukocyte Antigen (HLA) Testing in Pharmacogenomics.

Review 7. Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS)/Drug-Induced Hypersensitivity Syndrome (DiHS)-Readdressing the DReSS.

8. Specific HLA genotypes confer susceptibility to acute necrotizing encephalopathy.

Review 9. Drug-Induced Skin Adverse Reactions: The Role of Pharmacogenomics in Their Prevention.

Review 10. The HLA-A31:01* allele: influence on carbamazepine treatment.

Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients.

1. Carbamazepine hypersensitivity: progress toward predicting the unpredictable.

2. HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans.

Review 3. Pharmacokinetics and Pharmacogenetics of Carbamazepine in Children.

Review 4. The risk of cutaneous adverse reactions among patients with the HLA-A* 31:01 allele who are given carbamazepine, oxcarbazepine or eslicarbazepine: a perspective review.

5. Clinical features of and genetic predisposition to drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a single Korean tertiary institution patients-investigating the relation between the HLA -B*4403 allele and lamotrigine.

6. Human Leukocyte Antigen (HLA) Testing in Pharmacogenomics.

Review 7. Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS)/Drug-Induced Hypersensitivity Syndrome (DiHS)-Readdressing the DReSS.

8. Specific HLA genotypes confer susceptibility to acute necrotizing encephalopathy.

Review 9. Drug-Induced Skin Adverse Reactions: The Role of Pharmacogenomics in Their Prevention.

Review 10. The HLA-A*31:01 allele: influence on carbamazepine treatment.

Review 10. The HLA-A31:01* allele: influence on carbamazepine treatment.